Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts.
JAMA Facial Plast Surg. 2019 Dec 1;21(6):475-479. doi: 10.1001/jamafacial.2019.0808.
In light of the current opioid crisis, there exists a demonstrated need to balance adequate postrhinoplasty pain control with measured use of narcotics. If pain is inadequately controlled, patients may be unsatisfied with their elective surgical experience.
To characterize the association between patient-reported pain outcomes, objective opioid use, and perception of surgical success.
DESIGN, SETTING, AND PARTICIPANTS: A case series survey study was conducted from July 2018 to January 2019. Consecutive patients who underwent cosmetic and/or functional rhinoplasty by 2 facial plastic surgeons (D.A.S. and L.N.L.) at an academic medical center were surveyed 1 month after surgery.
The number of oxycodone tablets taken, patient-reported pain outcomes, number of narcotic prescription refills, and patient-reported functional and cosmetic outcomes were recorded. Perception of pain, surgical outcome, and oxycodone intake were also evaluated by sex. Demographic information and perception of surgical results were recorded. Statistical analysis was performed using STATA statistical software (version 12.0, STATA Corp). Spearman rank order correlation was used for ordinal, monotonic variables with P < .05 being considered statistically significant.
Overall, 104 patients were surveyed; 6 were lost to follow-up. Of the participants included, 50 were women with a mean (SD) age of 38 (16.0) years and 48 were men with a mean (SD) age of 38 (16.7) years. Although patients were prescribed a range of 10 to 40 tablets of oxycodone, patients took a mean (SD) of 5.2 tablets (range, 0-23). There were no significant sex differences in perception of pain, perception of outcome, or narcotic use. Among patients undergoing purely functional rhinoplasty, a statistically significant negative association between perception of pain and perception of functional outcome (breathing improvement) was evident. Patients who experienced less pain than they expected had a greater perception of functional improvement (rs = -0.62, P = .001). In contrast, among patients who underwent rhinoplasty with cosmetic improvement, no association was found between pain and perception of surgical outcome (rs = 0.05, P = .64).
To our knowledge, this is the first study to prospectively evaluate the association between opioid use, patient-reported pain, and perceived surgical success. These data may help guide preoperative counseling because patients who are interested purely in breathing improvement (without cosmetic change) may warrant additional pain-specific counseling to optimize patient satisfaction.
鉴于当前阿片类药物危机,需要平衡充分的隆鼻后疼痛控制与阿片类药物的合理使用。如果疼痛未得到充分控制,患者可能对他们的选择性手术体验不满意。
描述患者报告的疼痛结果、客观阿片类药物使用与手术成功感知之间的关联。
设计、地点和参与者:这是一项从 2018 年 7 月至 2019 年 1 月进行的病例系列调查研究。由 2 位面部整形医生(D.A.S. 和 L.N.L.)在学术医疗中心对连续接受美容和/或功能鼻整形术的患者进行调查,在术后 1 个月进行。
记录了羟考酮片的服用数量、患者报告的疼痛结果、阿片类药物处方的补充数量以及患者报告的功能和美容结果。还按性别评估了疼痛感知、手术结果和羟考酮摄入。记录了人口统计学信息和手术结果感知。使用 STATA 统计软件(版本 12.0,STATA 公司)进行统计分析。对于有序、单调变量,使用 Spearman 秩相关,P <.05 被认为具有统计学意义。
共有 104 名患者接受了调查,其中 6 名患者失访。纳入的参与者中,50 名女性的平均(SD)年龄为 38(16.0)岁,48 名男性的平均(SD)年龄为 38(16.7)岁。尽管患者被开了 10 到 40 片羟考酮,但平均服用了 5.2 片(范围 0-23 片)。在疼痛感知、手术结果感知或阿片类药物使用方面,性别之间没有显著差异。在仅接受功能性鼻整形术的患者中,疼痛感知与功能结果(呼吸改善)感知之间存在显著的负相关。与预期相比,经历疼痛较轻的患者对功能改善的感知更大(rs = -0.62,P =.001)。相比之下,在接受美容改善的鼻整形术患者中,疼痛与手术结果感知之间没有关联(rs = 0.05,P =.64)。
据我们所知,这是第一项前瞻性评估阿片类药物使用、患者报告的疼痛与感知手术成功之间关联的研究。这些数据可能有助于指导术前咨询,因为仅对呼吸改善(无美容改变)感兴趣的患者可能需要额外的疼痛特定咨询,以优化患者满意度。
3。